Complement and antibody enhance binding and uptake of HIV-1 by bone marrow cells.
van de Wiel
B A
BA
Department of Pathology, University Hospital, Utrecht, The Netherlands.
Bakker
L J
LJ
de Graaf
L
L
de Weger
R A
RA
Verhoef
J
J
van den Tweel
J G
JG
Joling
P
P
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D015703:Antigens, CD / Q000276:immunology; D018952:Antigens, CD34; D015214:Antigens, Differentiation, Myelomonocytic / Q000276:immunology; D001853:Bone Marrow / Q000378:metabolism / Q000821:virology; D001854:Bone Marrow Cells; D003176:Complement C3 / Q000494:pharmacology*; D005347:Fibroblasts / Q000276:immunology / Q000378:metabolism / Q000821:virology; D015497:HIV-1 / Q000378:metabolism*; D006412:Hematopoietic Stem Cells / Q000276:immunology / Q000378:metabolism / Q000821:virology; D006801:Humans; D018950:Lipopolysaccharide Receptors; D008264:Macrophages / Q000276:immunology / Q000378:metabolism / Q000821:virology; D009000:Monocytes / Q000276:immunology / Q000378:metabolism / Q000821:virology
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D018952:Antigens, CD34; D015214:Antigens, Differentiation, Myelomonocytic; D003176:Complement C3; D018950:Lipopolysaccharide Receptors